Patent ID: 6228859
Filing Date: 2001-05-08
Classification: A61P,C07D

Abstract:
A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a compound selected from the group consisting of:6-amino-3-(3-cyclopentyloxy-4-methoxy-benzyl)-8-isopropyl-3H-purine;3-(3-cyclopentyloxy-4-methoxy-benzyl)-6-ethylamino-8-(1-hydroxy-1-methyl-et hyl)-3H-purine;6-amino-3-(3-cyclopentyloxy-4-methoxy-benzyl)-8-(1-hydroxy-1-methyl-ethyl)- 3H-purine;6-ethylamino-3(3-((1RS, 3RS)-3-hydroxycyclopentyloxy)-4-methoxy-benzyl)-8-(1-hydroxy-1-methyl-ethy l)-3H-purine;6-amino-3-(3 -((1RS, 3RS)-3-hydroxycyclopentyloxy)-4-methoxy-benzyl)-8-(1-hydroxy-1-methyl-ethy l)-3H-purine;6-ethylamino-3-(3-((1RS, 3RS)-3-hydroxycyclopentyloxy)-4-methoxy-benzyl)-8-isopropyl-3H-purine;6-amino-3-(3 -((1RS, 3RS)-3-hydroxycyclopentyloxy)-4-methoxy-benzyl)-8-isopropyl-3H-purine;pharmaceutically acceptable salts thereof; andstereoisometric forms thereof.